✦ LIBER ✦

Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia

✍ Scribed by Frederick A. Schmitt; Martin R. Farlow; Xiangyi Meng; Sibel Tekin; Jason T. Olin

Book ID: 118076731
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 129 KB
Volume: 16
Category: Article
ISSN: 1755-5930
DOI: 10.1111/j.1755-5949.2010.00182.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of rivastigmine on tremor in pati

Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia

✍ Tanya Y. Gurevich; Herzel Shabtai; Amos D. Korczyn; Ely S. Simon; Nir Giladi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract The purpose of this study was to assess whether rivastigmine, a cholinergic agent, affects tremor features when given to improve cognition in demented Parkinson's disease (PD) patients. Demented PD patients (n = 26; Mini‐Mental State Examination score, 13–25; age, 75.2 ± 4.9 yr) were gi

Rivastigmine versus placebo in hyperhomo

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients

✍ Paolo Barone; David J. Burn; Teus van Laar; Chuanchieh Hsu; Werner Poewe; Roger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract The effects of rivastigmine versus placebo in Parkinson's disease dementia (PDD) patients with elevated or normal/low plasma homocysteine were determined. In this prospective analysis of a 24‐week, randomly assigned, placebo‐controlled study of rivastigmine in PDD, subpopulations compri

1.205 Longitudinal neuropsychometric ass

1.205 Longitudinal neuropsychometric assessment in patients with Parkinson's disease Dementia: Effect of rivastigmine

✍ J. Kassubek; A. Wierciochin; C.A.F. von Arnim 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Memory and executive function impairment

Memory and executive function impairment predict dementia in Parkinson's disease

✍ Gilberto Levy; Diane M. Jacobs; Ming-Xin Tang; Lucien J. Côté; Elan D. Louis; Br 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Utility of the Mattis dementia rating sc

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

✍ Kathy Dujardin; David Devos; Stéphane Duhem; Alain Destée; Rose-Marie Marié; Fra 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 89 KB

Effects of rivastigmine in patients with

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub